SlideShare a Scribd company logo
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Interpretn
Phases
General Points on
Hepatitis B Virus
Infection
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Interpretn
Phases
Learning Outcomes
At the end of this module, participants are
expected to:
• Be able to define the common terminologies
used regarding hepatitis B virus and outcome of
infection
• Differentiate acute from chronic infection
• Explain the clinical significance of the
serological markers of hepatitis B virus
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Image from Microbiology Info.com
• HBsAg, HBV surface antigen is on surface of virus.
• There is nucleocapsid core within the viral particle.
• HBcAg, HBV core antigen is on surface of nucleocapsid
• HBV DNA is in the inside of nucleocapsid
• HBeAg, HBV envelope antigen, is located between HBV
surface and core
• DNA Polymerase – enzyme that helps in the replication
of the HBV
Structure of Hepatitis B virus
Serology
Acute
vs
Patterns
Interpretn
Phases
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
HBV DNA (Viral load) | Quantitative or qualitative
Antigens Antibodies
HBsAg Hepatitis B surface Antigen Anti-HBs
HBcAg Hepatitis B core Antigen
(absent in blood)
IgM anti-HBc
IgG anti-HBc
HBeAg Hepatitis B e Antigen Anti-HBe
Types of Serological Markers for HBV
Acute
vs
Patterns
Interpretn
Phases
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Interpretn
Phases
*Breakwell et al, 2017
Marker Clinical significance
HBsAg Appears in blood in acute stage of infection and
persists in chronic infection
– Its an alternative to HBV DNA to monitor response
to treatment
IgM Anti-HBc IgM subclass of anti-HBc – this is a serological marker
of acute
infection.
Disappears in chronic infection (in the presence of
HBsAg)
HBeAg Indicates high viral load as well as high infectivity
(HBV patients in Africa have low prevalence of this
antigen*)
Anti-HBe Indicates decreasing viral load.
But may be absent in some mutant forms of HBV
infection
Anti-HBs Indicates recovery from hepatitis B infection
(in the presence of Anti-HBc IgG) or immunity from
vaccination
Clinical Significance of Serological Markers
for HBV
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Acute
6 months
Chronic
Acute versus chronic HBV
• The terms, acute and chronic as it refers to HBV
infection refers to a timeline rather than severity
• Acute means infection lasting less than 6 months
• Chronic means infection lasting beyond 6 months
Patterns
Interpretn
Phases
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Pattern of serological markers
in acute HBV infection
Patterns
Pattern of serological markers
in acute HBV infection
Interpretn
Phases
• The 1st serological marker to appear in blood is
HBsAg, followed by HBeAg and then anti-HB core
• Anti-HB core is like a scar that does not disappear,
even when one achieves HBsAg clearance
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Pattern of serological markers in
chronic HBV infection
Interpretn
Phases
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Interpretn
Phases Interpretation of serological markers in
HBV infection
HBsAg Anti-HBc IgG Anti-HBc IgM Anti-HBs Interpretation
- - - - Never exposed
(susceptible)
- + - + Past infection, cleared;
natural
immunity acquired
- + - - Past infection, cleared;
natural
immunity has waned over
time
- - - + Immunity due to
vaccination
- - + + Recent infection,
recovered;
immunity achieved
+ - + - Acute ongoing infection
+ + - - Chronic ongoing infection
Introduction and
generalities on viral
hepatitis
Outcomes
HBV
str
Serology
Acute
vs
Patterns
Interpretn
Phases
Phases of HBV infection by immune
response
Phases of HBV infection by
immune response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of
the phases in terms of clinical and
laboratory parameters
1
e tolerance
otolerant
stently normal
ve | HBeAb –ve
ry high
mal or mild
2
ance
se
ermittently
ve
an in immune
lammatory
3
rrier state
mal
+ve
(but upto
d
4
ns
5
e
Phases of HBV infection by immune
response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of the
phases in terms of clinical and
laboratory parameters
1
Phase 1: Immune tolerance
• Alternative term is immunotolerant
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is very high
• Liver histology – either normal or mild
inflammatory changes
2
ance
se
ermittently
ve
an in immune
lammatory
3
rrier state
mal
+ve
(but upto
d
4
ns
5
e
Phases of HBV infection by immune
response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of the
phases in terms of clinical and
laboratory parameters
1
Phase 1: Immune tolerance
• Alternative term is immunotolerant
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is very high
• Liver histology – either normal or mild
inflammatory changes
2
Phase 2: Immune clearance
• Alternative term is immune reactive phase
• Liver enzyme, ALT is persistently or
intermittently abnormal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is high, but less than in
immune tolerant phase
• Liver histology – moderate or severe
inflammatory changes
3
rrier state
mal
+ve
(but upto
d
4
ns
5
e
Phases of HBV infection by immune
response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of the
phases in terms of clinical and
laboratory parameters
1
Phase 1: Immune tolerance
• Alternative term is immunotolerant
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is very high
• Liver histology – either normal or mild
inflammatory changes
2
Phase 2: Immune clearance
• Alternative term is immune reactive phase
• Liver enzyme, ALT is persistently or intermittently
abnormal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is high, but less than in immune
tolerant phase
• Liver histology – moderate or severe inflammatory
changes
3
Phase 3: Immune control
• Alternative term is inactive HBsAg carrier state
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg -ve | HBeAb +ve
• HBV DNA (viral load) is <2,000 IU/mL (but
upto 20,000 IU/mL)
• Liver histology – either normal or mild
inflammatory changes
4
ns
5
e
Phases of HBV infection by immune
response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of the
phases in terms of clinical and
laboratory parameters
1
Phase 1: Immune tolerance
• Alternative term is immunotolerant
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is very high
• Liver histology – either normal or mild
inflammatory changes
2
Phase 2: Immune clearance
• Alternative term is immune reactive phase
• Liver enzyme, ALT is persistently or intermittently
abnormal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is high, but less than in immune
tolerant phase
• Liver histology – moderate or severe inflammatory
changes
3
Phase 3: Immune control
• Alternative term is inactive HBsAg carrier state
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg -ve | HBeAb +ve
• HBV DNA (viral load) is <2000IU/mL (but upto
20000IU/mL)
• Liver histology – either normal or mild
inflammatory changes
4
Phase 4: Immune escape
• Alternative term is HBeAg negative chronic
hepatitis B or reactivation (relapse)
• Liver enzyme, ALT is persistently or
intermittently abnormal
• Serology shows HBeAg -ve | HBeAb +ve
• HBV DNA (viral load) is >2,000 IU/mL
(fluctuates)
• Liver histology – Moderate to severe
inflammation and fibrosis +/- cirrhosis
• Predominance of HBV with precure mutations
5
e
Phases of HBV infection by immune
response
• These phases provide a summary of the
natural course of HBV infection
• The phases are not necessarily
sequential
• Strictly, there are 4 phases
• Next, we shall describe the events of the
phases in terms of clinical and
laboratory parameters
1
Phase 1: Immune tolerance
• Alternative term is immunotolerant
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is very high
• Liver histology – either normal or mild
inflammatory changes
2
Phase 2: Immune clearance
• Alternative term is immune reactive phase
• Liver enzyme, ALT is persistently or intermittently
abnormal
• Serology shows HBeAg +ve | HBeAb –ve
• HBV DNA (viral load) is high, but less than in immune
tolerant phase
• Liver histology – moderate or severe inflammatory
changes
3
Phase 3: Immune control
• Alternative term is inactive HBsAg carrier state
• Liver enzyme, ALT is persistently normal
• Serology shows HBeAg -ve | HBeAb +ve
• HBV DNA (viral load) is <2000IU/mL (but upto
20000IU/mL)
• Liver histology – either normal or mild
inflammatory changes
4
Phase 4: Immune escape
• Alternative term is HBeAg negative chronic
hepatitis B or reactivation (relapse)
• Liver enzyme, ALT is persistently or
intermittently abnormal
• Serology shows HBeAg -ve | HBeAb +ve
• HBV DNA (viral load) is
>2000IU/mL(fluctuates)
• Liver histology – Moderate to severe
inflammation and fibrosis +/- cirrhosis
• Predominance of HBV with precure mutations
5
Additional Phase: HBsAg
negative phase
• Alternative name is resolved hepatitis B
• Loss of HBsAg
• HBV DNA may remain detectable in the liver,
but not in the serum
• Some patients with HBsAg loss may still have
detectable HBV DNA in the serum (occult
HBV)
• The latter are vulnerable to HBV reactivation
following immunosuppression
Transmission of Hepatitis B Virus
Horizontal transmission
This by far the commonest mode of transmission in Africa
Occurs in family members and between child to child
Unsafe Blood transfusion
This was particularly the case before screening for
Infections prior to transfusion was commenced
Vertical transmission
From mother to child at:
Time of delivery (labour or shortly after- perinatal)
Or
Rarely in 2nd or third trimester of pregnancy
Transmission of Hepatitis B Virus
Blood and blood products contact
This includes needle stick injuries and contacts with blood
spills
Unhealthy medical practice
Razors, inadequate sterilization, dental and
surgical procedures
Intravenous drug use
This is not very commonly reported in Africans,
but may be contributing to adult acute infection cases
Transmission of Hepatitis B Virus
Non medical risks
Manicures, tattoos, sharing toothbrushes, traditional surgical
-scarification practice
-hair and barbing salons
Unprotected sexual contact
Most infections in Africans occur in childhood
For most adults with infections, only a small
proportion may have acquired HBV via hetero or
homo sexual routes
Groups at high risk
of Hepatitis B
Virus infection
Listen to this video first!
YouTube Video on Routes of transmission of HBV
Opens a new window!
Birth before 1985
(people who have ever received
unsafe blood or blood product)
Children born to HBV positive
mothers
These are less likely to clear the virus and thus become
chronic carriers – hence birth dose HBV vaccine is
paramount for prevention
Pregnant women Health care workers exposed
to biological fluids
Especially if they are engaged in exposure-prone
procedures
Risk to baby if mum has high HBV DNA, or is HBeAg +ve
Individuals infected with HIV
or HCV
Inmates of correctional
facilities – (prisoners)
Due to weakened immune systems
These tend to have risky behaviours and or live in
suboptimal conditions
Persons who have ever
injected drugs
Persons requiring
immunosuppressive therapy
These persons tend to share
needles in an unsafe way and thus
promote transmission of HBV
Immune systems are weakened and
chance of reversion of occult HBV is
high
Sex workers
Men having sex with men
History of multiple sexual
partners or STIs
Patients undergoing renal
dialysis
These individuals are dependent on
blood and blood products and
hence prone to infection
Cirrhosis
• Defined as an advanced stage of
liver disease characterized by
o extensive liver fibrosis
o nodularity of the liver
o alteration of liver architecture
o disrupted blood flow to the liver
Decompensated
cirrhosis
o Clinical complications of
cirrhosis including:
o Jaundice
• Ascites
• spontaneous bacterial peritonitis
• oesophageal varices
• hepatic encephalopathy
• sepsis and renal failure
More definitions
• Persistently abnormal LFTs
• Three ALT determinations above the upper limit of normal, made
at unspecified intervals during 6 to 12-month period or
predetermined intervals during a 12-month period
• HBeAg seroconversion: Loss of HBeAg and seroconversion to anti-HBe
• HBsAg seroconversion: Loss of HBsAg and development of anti-HBs
• HBeAg reversion: Reappearance of HBeAg in a person who was
previously HBeAg negative
• Presence of anti-HBc indicates:
• If HBsAg –ve: prior exposure to HBV
• If HBsAg +ve: current HBV infection
What you have learned in this module
• Commonly used terminologies about hepatitis B, including serology and phases of
infection
• Structure of hepatitis B virus and explanations about the various proteins
• Although described in phases, the course of hepatitis B infection is non-linear
• Patients fluctuate between immune tolerant phases through to immune clearance and
reversal
• Modes of transmission of HBV and groups at high risk were also defined
• Transmission of HBV in African is often horizontal, meaning that most infections occur
before the age of 5.
• Unsafe blood transfusion and use of unsterile equipment are also important
• HBV infection can lead to cirrhosis and its decompensation
General Points on Hepatitis B Virus
Infection
This ends the trial modules – Consider purchasing the
Liver Course for a complete set of modules
You have done well to have completed this
module:

More Related Content

What's hot

Hepatitis B prophylaxis and tratment ppt
Hepatitis B prophylaxis and tratment pptHepatitis B prophylaxis and tratment ppt
Hepatitis B prophylaxis and tratment ppt
uma advani
 
Hiv
HivHiv
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
PathKind Labs
 
Hepatitis B
Hepatitis BHepatitis B
Update on prevalence, diagnosis and treatment of Hepatitis B Virus
Update on prevalence, diagnosis and treatment of Hepatitis B VirusUpdate on prevalence, diagnosis and treatment of Hepatitis B Virus
Update on prevalence, diagnosis and treatment of Hepatitis B Virus
Prof. Hesham N. Mustafa
 
Viral hepatitis
Viral hepatitis Viral hepatitis
Viral hepatitis
Melaku Yetbarek,MD
 
Post exposure prophylaxis of hiv
Post exposure prophylaxis of hivPost exposure prophylaxis of hiv
Post exposure prophylaxis of hiv
Niranjan Chavan
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis B virus
Hepatitis B  virusHepatitis B  virus
Hepatitis B virus
Pandey Sunil
 
HIV
HIVHIV
HIV
BPKIHS
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
deepak deshkar
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
Oladele Situ
 
Hepatitis b and c prophylaxis
Hepatitis b and c prophylaxisHepatitis b and c prophylaxis
Hepatitis b and c prophylaxisSapeedeh Afzal
 
Viral hepatitis overview
Viral hepatitis overviewViral hepatitis overview
Viral hepatitis overview
Abdulganiyu Kabeeru
 
Tuberculosis and HIV Coinfection.ppt
Tuberculosis and HIV Coinfection.pptTuberculosis and HIV Coinfection.ppt
Tuberculosis and HIV Coinfection.ppt
MdMansurAalam2
 
Serology for viral hepatitis
Serology for viral hepatitisSerology for viral hepatitis
Serology for viral hepatitis
Mohammed Sabry
 
Hepatitis b (hbv)
Hepatitis b (hbv)Hepatitis b (hbv)
Hepatitis b (hbv)
OPTOM FASLU MUHAMMED
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis B
Arun Vasireddy
 
Hepatitis B Virus
Hepatitis B VirusHepatitis B Virus
Hepatitis B Virus
HuzaifaMD
 
Viral hepatitis B and C
Viral hepatitis B and CViral hepatitis B and C
Viral hepatitis B and C
D.A.B.M
 

What's hot (20)

Hepatitis B prophylaxis and tratment ppt
Hepatitis B prophylaxis and tratment pptHepatitis B prophylaxis and tratment ppt
Hepatitis B prophylaxis and tratment ppt
 
Hiv
HivHiv
Hiv
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Update on prevalence, diagnosis and treatment of Hepatitis B Virus
Update on prevalence, diagnosis and treatment of Hepatitis B VirusUpdate on prevalence, diagnosis and treatment of Hepatitis B Virus
Update on prevalence, diagnosis and treatment of Hepatitis B Virus
 
Viral hepatitis
Viral hepatitis Viral hepatitis
Viral hepatitis
 
Post exposure prophylaxis of hiv
Post exposure prophylaxis of hivPost exposure prophylaxis of hiv
Post exposure prophylaxis of hiv
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Hepatitis B virus
Hepatitis B  virusHepatitis B  virus
Hepatitis B virus
 
HIV
HIVHIV
HIV
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Hepatitis b and c prophylaxis
Hepatitis b and c prophylaxisHepatitis b and c prophylaxis
Hepatitis b and c prophylaxis
 
Viral hepatitis overview
Viral hepatitis overviewViral hepatitis overview
Viral hepatitis overview
 
Tuberculosis and HIV Coinfection.ppt
Tuberculosis and HIV Coinfection.pptTuberculosis and HIV Coinfection.ppt
Tuberculosis and HIV Coinfection.ppt
 
Serology for viral hepatitis
Serology for viral hepatitisSerology for viral hepatitis
Serology for viral hepatitis
 
Hepatitis b (hbv)
Hepatitis b (hbv)Hepatitis b (hbv)
Hepatitis b (hbv)
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis B
 
Hepatitis B Virus
Hepatitis B VirusHepatitis B Virus
Hepatitis B Virus
 
Viral hepatitis B and C
Viral hepatitis B and CViral hepatitis B and C
Viral hepatitis B and C
 

Similar to General aspects and definitions of hepatitis B

chronic hep.pptx
chronic hep.pptxchronic hep.pptx
chronic hep.pptx
AYUSHPRATAPSINGH64
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
Dr.Dinesh Jain
 
Virology of hepatitis
Virology of hepatitis Virology of hepatitis
Virology of hepatitis
Nur Amirah Mohd Jalil
 
Chronic Hepatitis B Infection
Chronic Hepatitis B InfectionChronic Hepatitis B Infection
Chronic Hepatitis B Infection
Hee Yan Han
 
09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt
HarishankarSharma27
 
Acute liver disease
Acute liver diseaseAcute liver disease
Acute liver disease
Deependra Shrestha
 
Laboratory.pptx
Laboratory.pptxLaboratory.pptx
Laboratory.pptx
ssuser3ef762
 
CHRONIC VIRAL HEPATITIS combined.pptx
CHRONIC VIRAL HEPATITIS combined.pptxCHRONIC VIRAL HEPATITIS combined.pptx
CHRONIC VIRAL HEPATITIS combined.pptx
ssuser0e95b9
 
Hepatitis B virus
Hepatitis B virus Hepatitis B virus
Hepatitis B virus
Pubali Biswas
 
immunodiagnosis of viral hepatitis students (1).ppt
immunodiagnosis of viral hepatitis students (1).pptimmunodiagnosis of viral hepatitis students (1).ppt
immunodiagnosis of viral hepatitis students (1).ppt
MUHAMMADCHAUDHRY39
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Dr Saikiran Reddy
 
Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitisRaeez Basheer
 
Hbv
HbvHbv
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
PathKind Labs
 
- LIVER DISORDERS - HEPATITIS helo hi hello hi
- LIVER DISORDERS - HEPATITIS helo hi hello hi- LIVER DISORDERS - HEPATITIS helo hi hello hi
- LIVER DISORDERS - HEPATITIS helo hi hello hi
harvynabatar2
 
Viraj Dis 2.pdf
Viraj Dis 2.pdfViraj Dis 2.pdf
Viraj Dis 2.pdf
MishiSoza
 
Hepatitispptfinal anoop k r
Hepatitispptfinal anoop k rHepatitispptfinal anoop k r
Hepatitispptfinal anoop k r
anoop k r
 
Chronic hepatitis
Chronic hepatitis Chronic hepatitis
Chronic hepatitis
ikramdr01
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Claudia Manay Astoria
 

Similar to General aspects and definitions of hepatitis B (20)

chronic hep.pptx
chronic hep.pptxchronic hep.pptx
chronic hep.pptx
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
 
Virology of hepatitis
Virology of hepatitis Virology of hepatitis
Virology of hepatitis
 
Chronic Hepatitis B Infection
Chronic Hepatitis B InfectionChronic Hepatitis B Infection
Chronic Hepatitis B Infection
 
09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt09_HBV_natural history......======....ppt
09_HBV_natural history......======....ppt
 
Acute liver disease
Acute liver diseaseAcute liver disease
Acute liver disease
 
Laboratory.pptx
Laboratory.pptxLaboratory.pptx
Laboratory.pptx
 
CHRONIC VIRAL HEPATITIS combined.pptx
CHRONIC VIRAL HEPATITIS combined.pptxCHRONIC VIRAL HEPATITIS combined.pptx
CHRONIC VIRAL HEPATITIS combined.pptx
 
Hepatitis B virus
Hepatitis B virus Hepatitis B virus
Hepatitis B virus
 
immunodiagnosis of viral hepatitis students (1).ppt
immunodiagnosis of viral hepatitis students (1).pptimmunodiagnosis of viral hepatitis students (1).ppt
immunodiagnosis of viral hepatitis students (1).ppt
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Acute viral hepatitis
Acute viral hepatitisAcute viral hepatitis
Acute viral hepatitis
 
Hbv
HbvHbv
Hbv
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
 
- LIVER DISORDERS - HEPATITIS helo hi hello hi
- LIVER DISORDERS - HEPATITIS helo hi hello hi- LIVER DISORDERS - HEPATITIS helo hi hello hi
- LIVER DISORDERS - HEPATITIS helo hi hello hi
 
Viraj Dis 2.pdf
Viraj Dis 2.pdfViraj Dis 2.pdf
Viraj Dis 2.pdf
 
Hepatitispptfinal anoop k r
Hepatitispptfinal anoop k rHepatitispptfinal anoop k r
Hepatitispptfinal anoop k r
 
Chronic hepatitis
Chronic hepatitis Chronic hepatitis
Chronic hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Petrol hbv siham
Petrol  hbv sihamPetrol  hbv siham
Petrol hbv siham
 

More from NimzingLadep

Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisdaySimple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
NimzingLadep
 
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatmentMANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
NimzingLadep
 
Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1
NimzingLadep
 
HEPATITIS B - AN OVERVIEW
HEPATITIS B - AN OVERVIEWHEPATITIS B - AN OVERVIEW
HEPATITIS B - AN OVERVIEW
NimzingLadep
 
Cure for hepatitis B - Is this attainable with current treatments?
Cure for hepatitis B - Is this attainable with current treatments?Cure for hepatitis B - Is this attainable with current treatments?
Cure for hepatitis B - Is this attainable with current treatments?
NimzingLadep
 
Introduction to eLearning on common health issues
Introduction to eLearning on common health issuesIntroduction to eLearning on common health issues
Introduction to eLearning on common health issues
NimzingLadep
 

More from NimzingLadep (6)

Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisdaySimple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
Simple Educational Slides on Hepatitis B #hepatitiscantwait #worldhepatitisday
 
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatmentMANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
 
Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1
 
HEPATITIS B - AN OVERVIEW
HEPATITIS B - AN OVERVIEWHEPATITIS B - AN OVERVIEW
HEPATITIS B - AN OVERVIEW
 
Cure for hepatitis B - Is this attainable with current treatments?
Cure for hepatitis B - Is this attainable with current treatments?Cure for hepatitis B - Is this attainable with current treatments?
Cure for hepatitis B - Is this attainable with current treatments?
 
Introduction to eLearning on common health issues
Introduction to eLearning on common health issuesIntroduction to eLearning on common health issues
Introduction to eLearning on common health issues
 

Recently uploaded

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 

Recently uploaded (20)

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 

General aspects and definitions of hepatitis B

  • 1.
  • 3. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Patterns Interpretn Phases Learning Outcomes At the end of this module, participants are expected to: • Be able to define the common terminologies used regarding hepatitis B virus and outcome of infection • Differentiate acute from chronic infection • Explain the clinical significance of the serological markers of hepatitis B virus
  • 4. Introduction and generalities on viral hepatitis Outcomes HBV str Image from Microbiology Info.com • HBsAg, HBV surface antigen is on surface of virus. • There is nucleocapsid core within the viral particle. • HBcAg, HBV core antigen is on surface of nucleocapsid • HBV DNA is in the inside of nucleocapsid • HBeAg, HBV envelope antigen, is located between HBV surface and core • DNA Polymerase – enzyme that helps in the replication of the HBV Structure of Hepatitis B virus Serology Acute vs Patterns Interpretn Phases
  • 5. Introduction and generalities on viral hepatitis Outcomes HBV str Serology HBV DNA (Viral load) | Quantitative or qualitative Antigens Antibodies HBsAg Hepatitis B surface Antigen Anti-HBs HBcAg Hepatitis B core Antigen (absent in blood) IgM anti-HBc IgG anti-HBc HBeAg Hepatitis B e Antigen Anti-HBe Types of Serological Markers for HBV Acute vs Patterns Interpretn Phases
  • 6. Outcomes HBV str Serology Acute vs Patterns Interpretn Phases *Breakwell et al, 2017 Marker Clinical significance HBsAg Appears in blood in acute stage of infection and persists in chronic infection – Its an alternative to HBV DNA to monitor response to treatment IgM Anti-HBc IgM subclass of anti-HBc – this is a serological marker of acute infection. Disappears in chronic infection (in the presence of HBsAg) HBeAg Indicates high viral load as well as high infectivity (HBV patients in Africa have low prevalence of this antigen*) Anti-HBe Indicates decreasing viral load. But may be absent in some mutant forms of HBV infection Anti-HBs Indicates recovery from hepatitis B infection (in the presence of Anti-HBc IgG) or immunity from vaccination Clinical Significance of Serological Markers for HBV
  • 7. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Acute 6 months Chronic Acute versus chronic HBV • The terms, acute and chronic as it refers to HBV infection refers to a timeline rather than severity • Acute means infection lasting less than 6 months • Chronic means infection lasting beyond 6 months Patterns Interpretn Phases
  • 8. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Patterns Pattern of serological markers in acute HBV infection Patterns Pattern of serological markers in acute HBV infection Interpretn Phases • The 1st serological marker to appear in blood is HBsAg, followed by HBeAg and then anti-HB core • Anti-HB core is like a scar that does not disappear, even when one achieves HBsAg clearance
  • 9. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Patterns Pattern of serological markers in chronic HBV infection Interpretn Phases
  • 10. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Patterns Interpretn Phases Interpretation of serological markers in HBV infection HBsAg Anti-HBc IgG Anti-HBc IgM Anti-HBs Interpretation - - - - Never exposed (susceptible) - + - + Past infection, cleared; natural immunity acquired - + - - Past infection, cleared; natural immunity has waned over time - - - + Immunity due to vaccination - - + + Recent infection, recovered; immunity achieved + - + - Acute ongoing infection + + - - Chronic ongoing infection
  • 11. Introduction and generalities on viral hepatitis Outcomes HBV str Serology Acute vs Patterns Interpretn Phases Phases of HBV infection by immune response
  • 12. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 e tolerance otolerant stently normal ve | HBeAb –ve ry high mal or mild 2 ance se ermittently ve an in immune lammatory 3 rrier state mal +ve (but upto d 4 ns 5 e
  • 13. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 Phase 1: Immune tolerance • Alternative term is immunotolerant • Liver enzyme, ALT is persistently normal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is very high • Liver histology – either normal or mild inflammatory changes 2 ance se ermittently ve an in immune lammatory 3 rrier state mal +ve (but upto d 4 ns 5 e
  • 14. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 Phase 1: Immune tolerance • Alternative term is immunotolerant • Liver enzyme, ALT is persistently normal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is very high • Liver histology – either normal or mild inflammatory changes 2 Phase 2: Immune clearance • Alternative term is immune reactive phase • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is high, but less than in immune tolerant phase • Liver histology – moderate or severe inflammatory changes 3 rrier state mal +ve (but upto d 4 ns 5 e
  • 15. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 Phase 1: Immune tolerance • Alternative term is immunotolerant • Liver enzyme, ALT is persistently normal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is very high • Liver histology – either normal or mild inflammatory changes 2 Phase 2: Immune clearance • Alternative term is immune reactive phase • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is high, but less than in immune tolerant phase • Liver histology – moderate or severe inflammatory changes 3 Phase 3: Immune control • Alternative term is inactive HBsAg carrier state • Liver enzyme, ALT is persistently normal • Serology shows HBeAg -ve | HBeAb +ve • HBV DNA (viral load) is <2,000 IU/mL (but upto 20,000 IU/mL) • Liver histology – either normal or mild inflammatory changes 4 ns 5 e
  • 16. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 Phase 1: Immune tolerance • Alternative term is immunotolerant • Liver enzyme, ALT is persistently normal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is very high • Liver histology – either normal or mild inflammatory changes 2 Phase 2: Immune clearance • Alternative term is immune reactive phase • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is high, but less than in immune tolerant phase • Liver histology – moderate or severe inflammatory changes 3 Phase 3: Immune control • Alternative term is inactive HBsAg carrier state • Liver enzyme, ALT is persistently normal • Serology shows HBeAg -ve | HBeAb +ve • HBV DNA (viral load) is <2000IU/mL (but upto 20000IU/mL) • Liver histology – either normal or mild inflammatory changes 4 Phase 4: Immune escape • Alternative term is HBeAg negative chronic hepatitis B or reactivation (relapse) • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg -ve | HBeAb +ve • HBV DNA (viral load) is >2,000 IU/mL (fluctuates) • Liver histology – Moderate to severe inflammation and fibrosis +/- cirrhosis • Predominance of HBV with precure mutations 5 e
  • 17. Phases of HBV infection by immune response • These phases provide a summary of the natural course of HBV infection • The phases are not necessarily sequential • Strictly, there are 4 phases • Next, we shall describe the events of the phases in terms of clinical and laboratory parameters 1 Phase 1: Immune tolerance • Alternative term is immunotolerant • Liver enzyme, ALT is persistently normal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is very high • Liver histology – either normal or mild inflammatory changes 2 Phase 2: Immune clearance • Alternative term is immune reactive phase • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg +ve | HBeAb –ve • HBV DNA (viral load) is high, but less than in immune tolerant phase • Liver histology – moderate or severe inflammatory changes 3 Phase 3: Immune control • Alternative term is inactive HBsAg carrier state • Liver enzyme, ALT is persistently normal • Serology shows HBeAg -ve | HBeAb +ve • HBV DNA (viral load) is <2000IU/mL (but upto 20000IU/mL) • Liver histology – either normal or mild inflammatory changes 4 Phase 4: Immune escape • Alternative term is HBeAg negative chronic hepatitis B or reactivation (relapse) • Liver enzyme, ALT is persistently or intermittently abnormal • Serology shows HBeAg -ve | HBeAb +ve • HBV DNA (viral load) is >2000IU/mL(fluctuates) • Liver histology – Moderate to severe inflammation and fibrosis +/- cirrhosis • Predominance of HBV with precure mutations 5 Additional Phase: HBsAg negative phase • Alternative name is resolved hepatitis B • Loss of HBsAg • HBV DNA may remain detectable in the liver, but not in the serum • Some patients with HBsAg loss may still have detectable HBV DNA in the serum (occult HBV) • The latter are vulnerable to HBV reactivation following immunosuppression
  • 18. Transmission of Hepatitis B Virus Horizontal transmission This by far the commonest mode of transmission in Africa Occurs in family members and between child to child Unsafe Blood transfusion This was particularly the case before screening for Infections prior to transfusion was commenced Vertical transmission From mother to child at: Time of delivery (labour or shortly after- perinatal) Or Rarely in 2nd or third trimester of pregnancy
  • 19. Transmission of Hepatitis B Virus Blood and blood products contact This includes needle stick injuries and contacts with blood spills Unhealthy medical practice Razors, inadequate sterilization, dental and surgical procedures Intravenous drug use This is not very commonly reported in Africans, but may be contributing to adult acute infection cases
  • 20. Transmission of Hepatitis B Virus Non medical risks Manicures, tattoos, sharing toothbrushes, traditional surgical -scarification practice -hair and barbing salons Unprotected sexual contact Most infections in Africans occur in childhood For most adults with infections, only a small proportion may have acquired HBV via hetero or homo sexual routes
  • 21. Groups at high risk of Hepatitis B Virus infection Listen to this video first! YouTube Video on Routes of transmission of HBV Opens a new window!
  • 22. Birth before 1985 (people who have ever received unsafe blood or blood product) Children born to HBV positive mothers These are less likely to clear the virus and thus become chronic carriers – hence birth dose HBV vaccine is paramount for prevention
  • 23. Pregnant women Health care workers exposed to biological fluids Especially if they are engaged in exposure-prone procedures Risk to baby if mum has high HBV DNA, or is HBeAg +ve
  • 24. Individuals infected with HIV or HCV Inmates of correctional facilities – (prisoners) Due to weakened immune systems These tend to have risky behaviours and or live in suboptimal conditions
  • 25. Persons who have ever injected drugs Persons requiring immunosuppressive therapy These persons tend to share needles in an unsafe way and thus promote transmission of HBV Immune systems are weakened and chance of reversion of occult HBV is high
  • 26. Sex workers Men having sex with men History of multiple sexual partners or STIs Patients undergoing renal dialysis These individuals are dependent on blood and blood products and hence prone to infection
  • 27. Cirrhosis • Defined as an advanced stage of liver disease characterized by o extensive liver fibrosis o nodularity of the liver o alteration of liver architecture o disrupted blood flow to the liver
  • 28. Decompensated cirrhosis o Clinical complications of cirrhosis including: o Jaundice • Ascites • spontaneous bacterial peritonitis • oesophageal varices • hepatic encephalopathy • sepsis and renal failure
  • 29. More definitions • Persistently abnormal LFTs • Three ALT determinations above the upper limit of normal, made at unspecified intervals during 6 to 12-month period or predetermined intervals during a 12-month period • HBeAg seroconversion: Loss of HBeAg and seroconversion to anti-HBe • HBsAg seroconversion: Loss of HBsAg and development of anti-HBs • HBeAg reversion: Reappearance of HBeAg in a person who was previously HBeAg negative • Presence of anti-HBc indicates: • If HBsAg –ve: prior exposure to HBV • If HBsAg +ve: current HBV infection
  • 30. What you have learned in this module • Commonly used terminologies about hepatitis B, including serology and phases of infection • Structure of hepatitis B virus and explanations about the various proteins • Although described in phases, the course of hepatitis B infection is non-linear • Patients fluctuate between immune tolerant phases through to immune clearance and reversal • Modes of transmission of HBV and groups at high risk were also defined • Transmission of HBV in African is often horizontal, meaning that most infections occur before the age of 5. • Unsafe blood transfusion and use of unsterile equipment are also important • HBV infection can lead to cirrhosis and its decompensation
  • 31. General Points on Hepatitis B Virus Infection This ends the trial modules – Consider purchasing the Liver Course for a complete set of modules You have done well to have completed this module: